FRANCE – Lesaffre, a prominent player in fermentation and microorganisms, announced the successful acquisition of DSM-Firmenich’s yeast extract business.
This strategic move enhances Lesaffre’s position in the savory ingredients market and aligns with its commitment to growth and innovation.
The acquisition follows a comprehensive review by DSM-Firmenich, which decided to divest from certain segments of its portfolio as part of a broader strategic realignment.
The deal, valued at approximately €120 million (US$129 million), marks a significant milestone for both companies.
Lesaffre will integrate DSM-Firmenich’s yeast derivatives processing technologies and the expertise of 46 employees previously involved in the yeast extract sector.
This integration is expected to bolster the capabilities of Biospringer, a Lesaffre business unit specializing in natural solutions derived from yeast fermentation.
“This transaction completely fits in our strategy to become a true global specialist in yeast extracts and derivatives for the savory ingredients market,” stated Brice-Audren Riché, CEO of Lesaffre.
The acquisition allows Lesaffre to leverage its extensive global manufacturing network better to serve its customers in savory and other fermentation-based applications.
As part of the agreement, Lesaffre will continue receiving yeast extracts produced by DSM-Firmenich at its Delft facility until 2025.
After this period, the Delft site will cease producing yeast extracts. However, Lesaffre has assured customers that they will experience no disruption in supply or service levels during this transition.
Patrick Niels, President of DSM-Firmenich’s Taste, Texture & Health business unit, emphasized the importance of this transaction for both companies.
“We have found the perfect home for our yeast extract business and those employees who will join Lesaffre,” he remarked.
He further highlighted that this partnership ensures continuity for customers who rely on DSM-Firmenich’s products while integrating them into Lesaffre’s innovative food solutions portfolio.
Lesaffre’s commitment to maintaining high-quality products and services throughout the integration process is paramount.
The companies are working closely to facilitate a smooth transition for all stakeholders, including employees and customers.
“We look forward to welcoming DSM-Firmenich employees within our Group to pave the way for sustained growth and expanded customer diversification,” Riché added.
As DSM-Firmenich focuses on refining its strategic objectives within nutrition, health, and beauty sectors, it remains committed to its Delft location, a vital hub for research and development in food applications.
This location houses over 1,000 employees dedicated to advancing food technology and is integral to DSM-Firmenich’s operations.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
